Clinical Trials Browser

Breast Neoplasms

Advanced Pancreatic Carcinoma

Glioblastoma

Stomach Neoplasms

Recurrence, Lymphoma, B-Cell

Lymphoma, Large B-Cell, Diffuse

Solid Neoplasms

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, HIV Infections, Liver Failure, Hepatic Insufficiency

Neoplasms by Site

Advanced Cancer

Prostatic Neoplasms

Multiple Myeloma

Adenocarcinoma, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Leukemia, Myeloid, Acute

Lymphoma, Lymphoma, Non-Hodgkin

Leukemia, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell

Multiple Myeloma

Squamous Cell Carcinoma of Head and Neck, Neoplasms, Squamous Cell

Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-in

Non-Muscle Invasive Bladder Neoplasms

Fibrosis, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Breast Neoplasms, Inflammatory Breast Neoplasms

Breast Neoplasms

Glioblastoma

Digestive System Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

High Risk Myeloid Malignancies

Breast Neoplasms

Glioblastoma

Breast Diseases, Breast Neoplasms, Triple Negative Breast Neoplasms

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Multiple Myeloma

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

Fallopian Tube Neoplasms, Ovarian Neoplasms

Clinical Trials

mBC

HCW9218 for Advanced Pancreatic Cancer

STERIMGLI

T-DXd_HER2Low

ZUMA-4

RICER

iintune-1

LIVERAL

An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors

RZD

Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer

A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia

AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies

Thal/Mel/Vel

Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Study of Surzebiclimab (BGB-A425) and Alcestobart (LBL-007) in Combination With Tislelizumab in Advanced Solid Tumors

A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors

VG-INFUSE Tria

A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Combination Study of SV-BR-1-GM With Retifanlimab

DENDR1

HERKULES-3

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies

Decreasing Polypharmacy in Older Adults With Curable Cancers Trial

SUMIT-ELA

Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy

Leflunomide in Previously Treated Metastatic Triple Negative Cancers

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

Study of DF1001 in Patients With Advanced Solid Tumors

A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer